HYBRID EVENT: Join us in person in Orlando, Florida, USA or attend virtually from anywhere.

8th Edition of Global Conference on

Addiction Medicine, Behavioral Health and Psychiatry

October 21-23, 2027 | Orlando, Florida, USA

Cognitive Enhancers in Addiction Recovery

Cognitive Enhancers in Addiction Recovery

Cognitive enhancers, also known as nootropics, are emerging as promising tools in addiction recovery. These substances aim to improve cognitive functions like memory, attention, and decision-making, which are often impaired by prolonged substance use. Medications such as modafinil, bupropion, and acetylcysteine have shown potential in reducing cravings and supporting cognitive recovery. These drugs work by modulating neurotransmitter systems, including dopamine and glutamate, to restore balance in the brain. Cognitive training programs, combined with these enhancers, further boost recovery outcomes by strengthening executive functions. While research is ongoing, the integration of cognitive enhancers offers a novel dimension to addiction treatment, improving both neurological health and quality of life.

Committee Members
Speaker at Addiction Medicine, Behavioral Health and Psychiatry 2027 - Christopher Ashton

Christopher Ashton

TeDDs on Chapel, Centre for Recovery, Canada
Speaker at Addiction Medicine, Behavioral Health and Psychiatry 2027 - John J Giordano

John J Giordano

Life Enhancement Recovery Center, United States
Speaker at Addiction Medicine, Behavioral Health and Psychiatry 2027 - Sam Vaknin

Sam Vaknin

Commonwealth Institute of Advanced Professional Studies (CIAPS), United Kingdom
Tags

Submit your abstract Today

Whatsapp